HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks clotting factor drugs in hemophilia a beginners
Disease control Recruiting nowThis study watches how well three clotting factor drugs (Nuwiq, Octanate, Wilate) work in real-world settings for people with severe hemophilia A who have had little or no prior treatment. Researchers will track bleeding events and side effects in about 200 participants. The goal…
Matched conditions: HAEMOPHILIA A
Sponsor: Octapharma • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New immune therapy aims to beat haemophilia's toughest complication
Disease control Recruiting nowThis study is testing a treatment called immune tolerance induction (ITI) in 300 people with haemophilia A who have developed inhibitors—antibodies that block the effectiveness of standard clotting factor therapy. The goal is to eliminate these inhibitors using high doses of indi…
Matched conditions: HAEMOPHILIA A
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New hope for hemophilia: trial tests drug to stop bleeding episodes
Disease control Recruiting nowThis study is testing a new medicine called SCT800 to prevent bleeding episodes in people with severe hemophilia A who have not been treated before. The goal is to see if regular infusions of SCT800 can safely reduce the number of bleeds. About 36 male participants will receive t…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 01, 2026 18:02 UTC
-
Researchers track Real-World use of clotting drug in iraqi hemophilia patients
Knowledge-focused Recruiting nowThis study will look at medical records of about 900 male children and adults with hemophilia A in Iraq to see how the clotting medicine turoctocog alfa is used in daily care. The goal is to understand bleeding rates and treatment patterns, but the study does not change or interf…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Timing your meals could make this hemophilia drug work better
Knowledge-focused Recruiting nowThis study tests a new medicine called Inno8 for hemophilia A. Researchers want to see how eating and drinking before and after taking the pill changes how much medicine gets into the blood. 80 healthy men aged 18-45 will take one dose after fasting, then wait different times bef…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 29, 2026 14:18 UTC